Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma

References

• Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19(6):1468–1470. doi:10.1158/1055-9965.EPI-10-001220501776
   PubMed Web of Science ®Google Scholar
• Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–1146. doi:10.1111/jgh.1328926749521
   PubMed Web of Science ®Google Scholar
• Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–146. doi:10.1093/jnci/dji02415657344
   PubMed Web of Science ®Google Scholar
• Reynolds JV, Donohoe CL, McGillycuddy E, et al. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. J Thorac Cardiovasc Surg. 2012;143(5):1130–1137 e1131. doi:10.1016/j.jtcvs.2011.12.00322244551
   PubMed Web of Science ®Google Scholar
• Modiano N, Gerson LB. Barrett‘s esophagus: incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag. 2007;3(6):1035–1145.18516262
   PubMedGoogle Scholar
• Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett‘s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125(6):1670–1677.14724819
   PubMed Web of Science ®Google Scholar
• Jankowski J, Bennett C, Jankowski JA. Management of Barrett esophagus: a practical guide for clinicians based on the BADCAT and BoB CAT recommendations. Pol Arch Med Wewn. 2015;125(10):765–770.26397112
   PubMed Web of Science ®Google Scholar
• Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett‘s esophagus. N Engl J Med. 2011;365(15):1375–1383. doi:10.1056/NEJMoa110304221995385
   PubMed Web of Science ®Google Scholar
• Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett‘s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103(13):1049–1057. doi:10.1093/jnci/djr20321680910
   PubMedGoogle Scholar
• Pohl H, Pech O, Arash H, et al. Length of Barrett‘s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65(2):196–201. doi:10.1136/gutjnl-2015-30922026113177
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American college of G. ACG clinical guideline: diagnosis and management of Barrett‘s Esophagus. Am J Gastroenterol. 2016;111(1):30–50;quiz 51. doi:10.1038/ajg.2015.322
   Web of Science ®Google Scholar
• Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51(8):751–767. doi:10.1007/s00535-016-1227-827325300
   PubMed Web of Science ®Google Scholar
• Inadomi JM. Surveillance in Barrett‘s esophagus: a failed premise. Keio J Med. 2009;58(1):12–18.19398879
   PubMedGoogle Scholar
• Gerson LB. Cost-analyses studies in Barrett‘s Esophagus: what is their utility? Gastroenterol Clin North Am. 2015;44(2):425–438. doi:10.1016/j.gtc.2015.02.01126021203
   PubMed Web of Science ®Google Scholar
• Yu D, Hopman WM, Paterson WG. Wait time for endoscopic evaluation at a Canadian tertiary care centre: comparison with Canadian association of gastroenterology targets. Can J Gastroenterol. 2008;22(7):621–626.18629391
   PubMed Web of Science ®Google Scholar
• Sharma P, Katzka DA, Gupta N, et al. Quality indicators for the management of Barrett‘s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American gastroenterological association symposium. Gastroenterology. 2015;149(6):1599–1606. doi:10.1053/j.gastro.2015.08.00726296479
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological A. American Gastroenterological association technical review on the management of Barrett‘s esophagus. Gastroenterology. 2011;140(3):e18–52;quiz e13. doi:10.1053/j.gastro.2011.01.031
   Web of Science ®Google Scholar
• Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett‘s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122(1):26–33.11781277
   PubMed Web of Science ®Google Scholar
• Shen O, Liu SF, Dawsey SM, et al. Cytologic screening for esophageal cancer: results from 12,877 subjects from a high-risk population in China. Int J Cancer. 1993;54(2):185–188.8486421
   PubMed Web of Science ®Google Scholar
• Liu SF, Shen Q, Dawsey SM, et al. Esophageal balloon cytology and subsequent risk of esophageal and gastric-cardia cancer in a high-risk Chinese population. Int J Cancer. 1994;57(6):775–780.8206671
   PubMed Web of Science ®Google Scholar
• Adams L, Roth MJ, Abnet CC, et al. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res (Phila). 2008;1(5):357–361. doi:10.1158/1940-6207.CAPR-08-006119137073
   PubMed Web of Science ®Google Scholar
• Korsten MA, Worner TM, Feinman L, Shaw S, Federman Q. Balloon cytology in screening of asymptomatic alcoholics for esophageal cancer, Part I. Dig Dis Sci. 1985;30(9):845–851.3896702
   PubMed Web of Science ®Google Scholar
• Tsang TK, Hidvegi D, Horth K, Ostrow JD. Reliability of balloon-mesh cytology in detecting esophageal carcinoma in a population of US veterans. Cancer. 1987;59(3):556–559.3791164
   PubMed Web of Science ®Google Scholar
• Falk GW, Chittajallu R, Goldblum JR, et al. Surveillance of patients with Barrett‘s esophagus for dysplasia and cancer with balloon cytology. Gastroenterology. 1997;112(6):1787–1797.9178668
   PubMed Web of Science ®Google Scholar
• Kadri SR, Lao-Sirieix P, O‘Donovan M, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett‘s oesophagus in primary care: cohort study. BMJ. 2010;341:c4372. doi:10.1136/bmj.c437220833740
   PubMed Web of Science ®Google Scholar
• Kadri S, Lao-Sirieix P, Fitzgerald RC. Developing a nonendoscopic screening test for Barrett‘s esophagus. Biomark Med. 2011;5(3):397–404. doi:10.2217/bmm.11.4021657849
   PubMed Web of Science ®Google Scholar
• Paterson AL, Lao-Sirieix P, O‘Donovan M, et al. Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms. Histopathology. 2017;70(2):203–210. doi:10.1111/his.13039.
   Web of Science ®Google Scholar
• Leoni-Parvex S, Mihaescu A, Pellanda A, Monnier P, Bosman FT. Esophageal cytology in the follow-up of patients with treated upper aerodigestive tract malignancies. Cancer. 2000;90(1):10–16.10692211
   PubMed Web of Science ®Google Scholar
• Katzka DA, Geno DM, Ravi A, et al. Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13(1):77–83 e72. doi:10.1016/j.cgh.2014.06.02624997328
   PubMed Web of Science ®Google Scholar
• Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett‘s esophagus. Gastroenterology. 2013;144(1):62–73 e66. doi:10.1053/j.gastro.2012.09.06023041329
   PubMed Web of Science ®Google Scholar
• Kumaravel A, Lopez R, Brainard J, Falk GW. Brush cytology vs. endoscopic biopsy for the surveillance of Barrett‘s esophagus. Endoscopy. 2010;42(10):800–805. doi:10.1055/s-0030-125571020821361
   PubMed Web of Science ®Google Scholar
• Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett‘s esophagus. Cancer. 1992;69(1):8–16.1727677
   PubMed Web of Science ®Google Scholar
• McIntire MG, Soucy G, Vaughan TL, Shahsafaei A, Odze RD. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol. 2011;35(7):1007–1013. doi:10.1097/PAS.0b013e318218940d21602660
   PubMed Web of Science ®Google Scholar
• Jaskiewicz K, Venter FS, Marasas WF. Cytopathology of the esophagus in Transkei. J Natl Cancer Inst. 1987;79(5):961–967.3479644
   PubMedGoogle Scholar
• Roshandel G, Merat S, Sotoudeh M, et al. Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran. Br J Cancer. 2014;111(12):2235–2241. doi:10.1038/bjc.2014.50625247319
   PubMed Web of Science ®Google Scholar
• Wright TC Jr., Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012;206(1):46 e41–46 e11. doi:10.1016/j.ajog.2011.07.02421944226
   PubMed Web of Science ®Google Scholar
• Mustafa RA, Santesso N, Khatib R, et al. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. Int J Gynaecol Obstet. 2016;132(3):259–265. doi:10.1016/j.ijgo.2015.07.02426851054
   PubMed Web of Science ®Google Scholar
• Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol. 2001;32(4):379–388. doi:10.1053/hupa.2001.2351111331954
   PubMed Web of Science ®Google Scholar
• Kerkhof M, van Dekken H, Steyerberg EW, et al. Grading of dysplasia in Barrett‘s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology. 2007;50(7):920–927. doi:10.1111/j.1365-2559.2007.02706.x17543082
   PubMed Web of Science ®Google Scholar
• Saad RS, Mahood LK, Clary KM, Liu Y, Silverman JF, Raab SS. Role of cytology in the diagnosis of Barrett‘s esophagus and associated neoplasia. Diagn Cytopathol. 2003;29(3):130–135. doi:10.1002/dc.1033412951679
   PubMed Web of Science ®Google Scholar